Athénaïs van der Elst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Athénaïs van der Elst has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Pascal Machiels
Pôle oncologie, Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain (UCLouvain), Brussels, Belgium
35 shared publications - Rachel Galot
Pôle oncologie, Institut de Recherche Clinique et Expérimentale, Université catholique de Louvain (UCLouvain), Brussels, Belgium
35 shared publications - Bernd Bodenmiller
Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland
34 shared publications - Caroline Even
24Head and Neck Department, Gustave Roussy, Villejuif, France
34 shared publications - Céline Lefebvre
IMMUcan Consortium, Brussels, Belgium
34 shared publications - Daniel Herrero-Saboya
IMMUcan Consortium, Brussels, Belgium
34 shared publications
Latest Publications
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S2. Study workflow and multi-omics approach
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S10. p-EMT and TLS signatures are prognostic factors in R/M SCCHN
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S3. Three multiplex immunofluorescent staining of SCCHN samples with 3 different 6-plex panels and their deconvolution
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S6. Genomic and transcriptomic alterations linked to HPV status
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S4. FFPE vs frozen tumor biopsies comparisons
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S5. HPV status affects the genomic and transcriptomic profiles but not the immune infiltration
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S5. HPV status affects the genomic and transcriptomic profiles but not the immune infiltration
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S7 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S7. Genomic alterations associated with substance abuse and primary disease location.
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S7 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S7. Genomic alterations associated with substance abuse and primary disease location.
- Open Access
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S9. The treatment history has an impact on the molecular and immune landscape of R/M SCCHN, related to Figure 3.
- 14 September 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Molecular and Immune Landscape of Recurrent and/or Distant Metastatic Squamous Cell Carcinoma of the Head and Neck: An EORTC/IMMUCAN Project
Figure S9. The treatment history has an impact on the molecular and immune landscape of R/M SCCHN, related to Figure 3.